logo
Plus   Neg
Share
Email

Sanofi To Create Production Site, Research Center In France Dedicated To Vaccines

Sanofi (SNYNF,SNY) announced the company will invest 610 million euros to create a production site and research center in France with both dedicated to vaccines. The company will create its Evolutive Vaccine Facility in Neuville sur Saône with an investment of 490 million euros over a five-year period. Sanofi has also committed to investing 120 million euros to create a new R&D center to develop future vaccines.

"By investing in a new industrial site and a R&D center, Sanofi positions France at the core of its strategy, aiming to make France a world-class center of excellence in vaccine research and production," said Paul Hudson, CEO at Sanofi.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon.com, Inc. can be held liable for damages caused by defective goods sold on its Marketplace including third parties, according to a ruling by a California appeals court. The California Fourth District Court of Appeals was pronouncing the ruling in a case where a defective replacement laptop battery caught fire and inflicted a woman with third-degree burns. Facebook has launched "Voting Information Center" on Facebook and Instagram platforms, with a view to boosting the number of Americans vote in the upcoming U.S. presidential election in November. The social media giant's latest initiative is expected to help 4 million voters register this year, and help them navigate a 'confusing election process'. Epic Games Inc., the developer of popular game Fortnite, has filed lawsuits against both Apple Inc. and Google after they removed the game from their app stores. The development reflects disputes related to app store fee the tech giants take from each purchase. Epic Games, which has been against the 30 percent revenue cut the two tech giants take from paid apps, added a direct payment option.
Follow RTT